Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressants to prevent relapse in depression
ISRCTN15969819Phase 4Completed
- Sponsor
- PRIMENT Clinical Trials Unit
- Start
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of citalopram, sertraline, fluoxetine and mirtazapine in major depressive disorder (MDD) (2 arms), sponsored by PRIMENT Clinical Trials Unit. Primary endpoint: Time to depressive relapse. Started Mar 2017; status: completed.
02
Drugs
citalopramsertralinefluoxetinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN15969819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15969819.